We have followed Sharps Compliance for a long time.
It is a well-managed company with a strong balance sheet. It is expanding through acquisitions. However, it is prudently managed and not growing for the sake of growing. Its new product med safe is doing well. Recently it has acquired a government contract. So overall, we are upbeat about the company’s future and decided to go long. In 2015, the company’s stock had skyrocketed due to Ebola fear and investors’ optimism over its professional market growth. Now its professional market growth has hit a slight speed bump, and the stock has taken a nosedive. The stock price has reached our entry point.
Disclaimer : InvestorDestination.com is not operated by a broker, a dealer, or a registered investment advisor. Under no circumstances does any information posted on investordestination.com represent a recommendation to buy or sell a security. In no event shall investordestination.com be liable to any visitor or third party for any damages of any kind arising out of the use of any content published or available on investordestination.com, or relating to the use of, or inability to use, investordestination.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security. The information on this site is in no way guaranteed for completeness, accuracy or in any other way.